Company profile
Inhibitor Therapeutics, Inc. Insider Trading
INTIEvery SEC Form 4 insider trading filing for Inhibitor Therapeutics, Inc. (INTI) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- OTC
- Sector
- Pharmaceutical Preparations
- CIK
- 0001042418
- Filings
- 20
- Insiders
- 9
- Last filing
- 2026-07-01
Activity summary
No insider transactions in the last 30 days. The most recent was on July 1, 2026, when Black Robe Capital LLC reported 3,200,000 shares (Gift). 20 filings from 9 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Inhibitor Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.
90 day insight
Over the last 90 days, Inhibitor Therapeutics, Inc. insiders filed 1 Form 4 transaction, none of which were open-market purchases or sales.
- Most active insider: Black Robe Capital LLC with 1 transaction totaling $0.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Black Robe Capital LLC | INTI | Gift | 3,200,000 | — | — |
| May 5, 2026 | Niraj Vasisht | INTI | Award | 50,000 | — | — |
| May 4, 2026 | Michael Allen Jerman | INTI | Award | 50,000 | — | — |
| May 4, 2026 | Francis E Odonnell Jr | INTI | Award | 50,000 | — | — |
| May 4, 2026 | Samuel P Sears Jr | INTI | Award | 50,000 | — | — |
17 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=INTI" \
-H "X-Api-Key: $KEY"